Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCRS1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,980
Award facts
- Contract value 100% obligated
- $13,979.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,979.52 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. The contract, issued on January 2, 2026, with an ultimate completion date of January 26, 2026, operates under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued pursuant to DMS Pharmaceutical Group's larger Indefinite Delivery Contract under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for supporting Department of Defense pharmaceutical supply requirements worldwide.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the federal military medical supply chain, leveraging its established small business status to compete in unrestricted federal procurement. The company's comprehensive product portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with demonstrated performance across numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. The award of this Xolair delivery order reflects the contractor's capability to fulfill specialized pharmaceutical requirements for Department of Defense healthcare operations, with no identified subcontractors supporting contract performance.
Quick answers
Who was awarded contract SPE2DR26FCRS1?
SPE2DR26FCRS1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FCRS1 worth?
The government has obligated $13,980 on SPE2DR26FCRS1.
Is contract SPE2DR26FCRS1 an order under another contract?
Yes. SPE2DR26FCRS1 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRS1 competed?
The extent of competition for SPE2DR26FCRS1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award